These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 22508748)
1. ACP Journal Club. Adding niacin to simvastatin did not improve clinical outcomes in patients with CV disease and dyslipidemia. Smith DA Ann Intern Med; 2012 Apr; 156(8):JC4-08. PubMed ID: 22508748 [No Abstract] [Full Text] [Related]
2. ACP Journal Club. Intensifying glucose control and adding fenofibrate to simvastatin each reduced progression of retinopathy in type 2 diabetes. Bronson DL Ann Intern Med; 2010 Nov; 153(10):JC5-10. PubMed ID: 21079205 [No Abstract] [Full Text] [Related]
3. ACP Journal Club. Adding omeprazole to clopidogrel reduced GI events and did not increase CV events. Chow CK Ann Intern Med; 2011 Mar; 154(6):JC3-7. PubMed ID: 21403070 [No Abstract] [Full Text] [Related]
4. Safety of niacin and simvastatin combination therapy. Bays H Am J Cardiol; 2008 Apr; 101(8A):3B-8B. PubMed ID: 18375239 [TBL] [Abstract][Full Text] [Related]
5. ACP Journal Club. Adding clopidogrel to proton-pump inhibitors was not associated with increased CV risk after MI. Aronow HD Ann Intern Med; 2010 Dec; 153(12):JC6-13. PubMed ID: 21173402 [No Abstract] [Full Text] [Related]
6. A new paradigm for managing dyslipidemia with combination therapy: laropiprant + niacin + simvastatin. Yiu KH; Cheung BM; Tse HF Expert Opin Investig Drugs; 2010 Mar; 19(3):437-49. PubMed ID: 20141348 [TBL] [Abstract][Full Text] [Related]
7. ACP Journal Club. Adding prompt revascularization to medical therapy did not reduce mortality or CV events in patients with type 2 diabetes and CAD. Poirier P Ann Intern Med; 2009 Oct; 151(8):JC4-5. PubMed ID: 19841443 [No Abstract] [Full Text] [Related]
8. ACP Journal Club. Adding metformin to insulin did not improve a composite of microvascular and macrovascular disease in type 2 diabetes. Fonseca V Ann Intern Med; 2009 Jul; 151(2):JC1-12. PubMed ID: 19620156 [No Abstract] [Full Text] [Related]
9. ACP Journal Club. Candesartan did not improve clinical or functional outcomes in patients with acute stroke and elevated BP. Frieden R Ann Intern Med; 2011 Jun; 154(12):JC6-5. PubMed ID: 21690583 [No Abstract] [Full Text] [Related]
10. ACP Journal Club. Valsartan reduced diabetes but not CV events in patients with impaired glucose tolerance and CV risk factors. Ann Intern Med; 2010 Jun; 152(12):JC6-9. PubMed ID: 20547903 [No Abstract] [Full Text] [Related]
11. ACP Journal Club. Review: Adding noninvasive ventilation to standard therapy improves outcomes in patients with some causes of acute respiratory failure. Shafazand S Ann Intern Med; 2011 Jun; 154(12):JC6-7. PubMed ID: 21690585 [No Abstract] [Full Text] [Related]
12. ACP Journal Club. Nateglinide did not reduce diabetes or CV events in patients with impaired glucose tolerance and CV risk factors. Farkouh M Ann Intern Med; 2010 Jun; 152(12):JC6-10. PubMed ID: 20547892 [No Abstract] [Full Text] [Related]
13. Effects of low-dose of niacin associated to simvastatin in the treatment of mixed dyslipidemia Salgad. Salgado BJ; Salgado JV; Dos Santos AM; Casulari LA Minerva Cardioangiol; 2010 Oct; 58(5):531-42. PubMed ID: 20948500 [TBL] [Abstract][Full Text] [Related]
14. ACP Journal Club: adding renal dysfunction to CHADS2 did not improve prediction of stroke or systemic embolism in AF. Clase CM; Zimmerman DL; A Thomson BK Ann Intern Med; 2013 Apr; 158(8):JC13. PubMed ID: 23588766 [No Abstract] [Full Text] [Related]
15. ACP Journal Club. Review: Adding antiviral drugs to steroids did not improve facial muscle recovery in Bell palsy. Davenport RJ Ann Intern Med; 2010 Feb; 152(4):JC-210. PubMed ID: 20157122 [No Abstract] [Full Text] [Related]
16. ACP Journal Club. Adding revascularization to medical therapy did not improve renal function in atherosclerotic renal artery stenosis. Hackam DG; Garg AX Ann Intern Med; 2010 Feb; 152(4):JC-26. PubMed ID: 20157130 [No Abstract] [Full Text] [Related]
17. Drug utilization patterns and cardiovascular outcomes in elderly patients newly initiated on atorvastatin or simvastatin. Swindle JP; Potash J; Kulakodlu M; Kuznik A; Buikema A Am J Geriatr Pharmacother; 2011 Dec; 9(6):471-82. PubMed ID: 22019005 [TBL] [Abstract][Full Text] [Related]
18. ACP Journal Club: Review: Evidence for the effectiveness of vitamin D and calcium for reducing CV outcomes, cancer, and death is limited. Simon JA Ann Intern Med; 2009 Nov; 151(10):JC5-5. PubMed ID: 19920263 [No Abstract] [Full Text] [Related]
19. ACP Journal Club. Review: Statins reduce mortality and cardiovascular (CV) morbidity in patients with low CV risk. Muñoz D; Granger CB Ann Intern Med; 2012 Apr; 156(8):JC4-07. PubMed ID: 22508747 [No Abstract] [Full Text] [Related]
20. ACP Journal Club. Review: ACE-Is or ARBs reduce adverse CV outcomes regardless of baseline systolic blood pressure. Singh V Ann Intern Med; 2012 Jul; 157(2):JC2-8. PubMed ID: 22801699 [No Abstract] [Full Text] [Related] [Next] [New Search]